INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript March 30, 2026 INmune Bio, Inc. beats earnings expectations.
California speaker specialists Bumpboxx have taken their expertise and added a side order of retro inspiration to create this ...
What Hi-Fi? on MSN
Quad launches the Platina CDT premium CD transport
Promising to be "last disc-spinner" you'll ever need ...
Q4 2025 Earnings Call March 30, 2026 4:30 PM EDTCompany ParticipantsDaniel Carlson - Head of Investor RelationsDavid Moss ...
INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announces its financial ...
Why Zip disks and LS-120s couldn't defeat the 1.44MB disk ...
Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 Obtained alignment with FDA and global regulators for planned Phase 3 trial design in ...
The 3.5-inch floppy disk isn’t dead, it’s just been repurposed. The same Nik Bentel Studio that turned a purse into an RC car ...
INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announces its financial results for the year ended December 31, 2025 ...
Czarny explores why modern cyber threats require a prevention-first security approach TAMPA, Fla., March 19, 2026 /PRNewswire/ -- OPSWAT Founder and CEO Benny Czarny has released his first book ...
EVE (NYSE:EVEX) highlighted progress on its eVTOL development program during its fourth quarter and full-year 2025 earnings call, emphasizing early flight-testing milestones, continued work with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results